Netherlands vs Timor-Leste: Treatment success rate for patients treated for MDR-TB
Netherlands
91.0%
in 2021
Timor-Leste
95.0%
in 2022
Netherlands rank
21st
Timor-Leste rank
18th
Treatment success rate for patients treated for MDR-TB over time
- Netherlands
- Timor-Leste
How they compare
Timor-Leste currently reports 95.0% against 91.0% in Netherlands, a difference of 4.0%.
The two have swapped places 8 times across 13 shared years of data; in 2009 it was Netherlands ahead.
Netherlands ranks 21st and Timor-Leste ranks 18th of 163 countries.
Netherlands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Netherlands | Timor-Leste | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 60.0% | 0.0% | 60.0% | Netherlands |
| 2010s | 77.0% | 75.0% | 2.0% | Netherlands |
| 2020s | 95.5% | 82.5% | 13.0% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Netherlands or Timor-Leste?
- Timor-Leste, at 95.0% against 91.0% in Netherlands as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Netherlands and Timor-Leste?
- 4.0%, with Timor-Leste ahead.
- How many years of comparable data are there for Netherlands and Timor-Leste?
- 13 years are reported by both, from 2009 to 2021.
- How do Netherlands and Timor-Leste rank globally for treatment success rate for patients treated for mdr-tb?
- Netherlands ranks 21st and Timor-Leste ranks 18th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.